Sowell Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sowell Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	838 +84	+11%	+$25.3K	0.01%	956
2026 Q1	$250K	Buy	754 +109	+17%	+$37.1K	0.01%	915
2025 Q4	$256K	Sell	645 -9	-1%	-$3.98K	0.01%	896
2025 Q3	$298K	Buy	654 +38	+6%	+$15.5K	0.01%	811
2025 Q2	$201K	Buy	+616	New	+$170K	0.01%	972
2021 Q2	–	Sell	-333	Closed	-$44K	–	593
2021 Q1	$44K	Buy	333 +118	+55%	+$17.8K	﹤0.01%	1706
2020 Q4	$28K	Hold	215	–	–	﹤0.01%	1598
2020 Q3	$31K	Hold	215	–	–	﹤0.01%	1371
2020 Q2	$32K	Sell	215 -110	-34%	-$14.8K	﹤0.01%	1310
2020 Q1	$35K	Sell	325 -198	-38%	-$22.9K	﹤0.01%	1170
2019 Q4	$60K	Buy	523 +498	+1,992%	+$49.6K	﹤0.01%	1092
2019 Q3	$2K	Buy	+25	New	+$1.98K	﹤0.01%	2028

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's ALNY Position: Q2 2026 in Review

Sowell Financial Services increased its Alnylam Pharmaceuticals (ALNY) stake by 11% in Q2 2026, buying an estimated $25.3K and bringing the position to 838 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #956.

Sowell Financial Services first reported a position in ALNY in Q3 2019 and has held it in 12 quarters since. The position peaked at $298K in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Sowell Financial Services held 838 shares of Alnylam Pharmaceuticals worth $252K as of Q2 2026.
Sowell Financial Services bought 84 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $25.3K.
Alnylam Pharmaceuticals made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #956 holding.
Sowell Financial Services first reported a position in Alnylam Pharmaceuticals in Q3 2019 and has held it in 12 quarters since.
Sowell Financial Services's Alnylam Pharmaceuticals position peaked at $298K in Q3 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.